FDA inspection
Mirgen Pharmaceutical: FDA inspection ending Jan 30, 2012
FDA inspection 764757 · Voluntary Action Indicated (VAI) · Boise, ID
Key facts
| Inspection ID | 764757 |
|---|---|
| Firm | Mirgen Pharmaceutical |
| FEI number | 3009078612 |
| Address | 12554 W Bridger Street, Suite 120 |
| City | Boise |
| State | ID |
| ZIP | 83713 |
| Country | United States |
| Fiscal year | 2012 |
| Inspection end date | Jan 30, 2012 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data